NUMB and endometrial carcinoma: Kaplan–Meier survival analysis demonstrated that endometrial carcinoma patients with NUMB alterations had significantly better overall survival compared to unaltered cases (p = 9.119 × 10−3), with 92% vs. 73% survival at 100 months.